— Ticker · NYQ —
DHR · Danaher Corporation
Healthcare · Diagnostics & Research
DHR
$231.72
▲ +0.86%
7-day move
7-day move
day$230.00 → $233.5252-wk$160.93 → $242.80avg vol4.0M / 3Mcap$162.9B
Plate I.
The Past Year, in One Line
The Valuation
| P/E (forward) | 24.9 |
| P/E (trailing) | 38.4 |
| EPS (forward) | $9.32 |
| EPS (trailing) | $6.04 |
| PEG | 1.32 |
| Dividend | 69.00% |
The Risk
| Beta | 0.80 |
| Short % float | 1.30% |
| Float | 626.3M |
| Shares out | 703.0M |
| Avg vol (3M) | 4.0M |
| 52w range | $160.93 → $242.80 |
The Analyst Tape
strong buybuyholdunderperformsell
$259.90
avg 12-mo target
+12.2%
vs. last · 21 analysts
At a Glance
$162.9B
market cap (USD)
exchangeNYQ
sectorHealthcare
industryDiagnostics & Research
market cap$162.9B
websitedanaher.com
The Briefs
live, polled every 60 seconds · Alpaca / Benzinga
No recent headlines for DHR in the last 7 days.
Word on the Street
StockTwits public feed · self-tagged bull/bear
No recent StockTwits posts for DHR.
Indicators That Mention DHR
8 of our 658 catalog map to DHR
SP-1251
AbbVie
Pharma mega-cap. Production tell via epa_abbv_waste.
49%
49%
49%
49%
↓52%
48%
●Still works on fresh data
r=-0.10
SP-1365
Pfizer
Big pharma. Vaccine + small-molecule production via epa_pfe_waste.
49%
49%
50%
49%
49%
49%
●Still works on fresh data
r=-0.03
SP-3079
XLV Healthcare ETF
Healthcare SPDR — pharma + biotech + insurers + devices. Broader than UNH alone.
49%
49%
50%
49%
50%
51%
●Still works on fresh data
r=-0.03
SP-1458
UnitedHealth Group
Biggest US health insurer. Pricing power = consumer cost forecast.
49%
49%
49%
49%
50%
51%
●Still works on fresh data
r=-0.04
SP-3601
ABBV TRI Chemical Releases
Annual chemical releases from AbbVie US plants. Pharma batch chemistry.
50%
50%
50%
50%
50%
50%
◐Too new to retest
r=0.00
SP-3174
AbbVie Hazardous Waste Tonnage
Monthly hazardous waste from AbbVie US plants. Drug batch chemistry, mixed-clean signal.
50%
50%
50%
50%
50%
50%
○Not yet retested on fresh data
r=0.00
SP-3646
LLY TRI Chemical Releases
Annual chemical releases from Eli Lilly US plants. Pharma production (incl. GLP-1).
50%
50%
50%
50%
50%
50%
◐Too new to retest
r=0.00
SP-3667
MRK TRI Chemical Releases
Annual chemical releases from Merck US plants. Pharma + vaccine production.
50%
50%
50%
50%
50%
50%
◐Too new to retest
r=0.00
Standard Poorly Disclaimer
We tested 658 indicators against six horizons. By chance alone, ~197 of these correlations should look "significant." Walk-forward out-of-sample is the only thing we trust.Other Players in the Pipeline
Healthcare · by market cap · 7-day move
— Voices on DHR —commentarylive
Curated commentary (Kobeissi, Doomberg, Lyn Alden, QuoteTheRaven, Pomp, ZeroHedge) mentioning DHR. Opinion, not wire.
No recent commentary mentioning DHR in the last 7 days.
Analyst · previewYou're seeing the public read on DHR. Analyst unlocks every pundit call on DHR with open P&L + alerts when a new position opens + the full related-indicator firing history. Trader adds intraday quotes + cross-asset co-fire scoring with DHR as the target + the API / MCP feed.Compare tiers →